δ-8-Tetrahydrocannabinol - 20 mg/ml solution in methanol

CAS: 5957-75-5

Ref. 3D-FT28082

Información del producto

• Nombre: δ-8-Tetrahydrocannabinol - 20 mg/ml solution in methanol
• Sinónimos: delta-8-THC, (-)-delta(sup 6)-3,4-trans-Tetrahydrocannabinol, (-)-delta(sup 8)-trans-Tetrahydrocannabinol, (-)-delta-(sup8)-trans-Tetrahydrocannabinol, (-)-delta8-Tetrahydrocannabinol, (-)-trans-Δ⁸-Tetrahydrocannabinol, (-)-Δ⁶-Tetrahydrocannabinol, (-)-Δ⁸-6a,10a-trans-Tetrahydrocannabinol, (-)-Δ⁸-THC, (-)-Δ⁸-Tetrahydrocannabinol, (-)-Δ⁸-trans-Tetrahydrocannabinol, (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol, (6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, 1-trans-delta(sup 8)-Tetrahydrocannabinol, 1-trans-delta-(sup8)-Tetrahydrocannabinol, 6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol, 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,10,10a-tetrahydro-3-pentyl-6,6,9-trimethyl-, trans(-)-, 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-, 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-, 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-(-)-, Brn 0023921, Cannabinol, 1-trans-delta(sup 8)-tetrahydro-, Cannabinol, 1-trans-delta-(sup8)-tetrahydro-, Cannabinol, delta1(6)-tetrahydro-, Cannabinol, Δ¹⁽⁶⁾-tetrahydro-, D8-Thc, DEA No. 7370, Nsc 134453, Tetrahydrocannabinols, Tetrahydrocannabinols (-)-delta6-3,4-trans-form, delta(sup 6)-Thc, delta(sup 8)-Thc, delta-(sup6)-THC, delta-(sup8)-THC, delta-8-Tetrahydrocannabinol, delta1(6)-trans-Tetrahydrocannabinol, delta6-Tetrahydrocannabinol, delta8-THC, l-Δ⁸-Tetrahydrocannabinol, trans-delta8-Tetrahydrocannabinol, Δ¹⁽⁶⁾-Tetrahydrocannabinol, Δ¹⁽⁶⁾-trans-Tetrahydrocannabinol, Δ⁸-l-Tetrahydrocannabinol

Descripción

Delta8-Tetrahydrocannabinol is an analytical method that is used to measure the concentration of tetrahydrocannabinol in human serum. This compound binds to the CB2 receptor and has been shown to have clinical relevance. Delta8-Tetrahydrocannabinol has also been shown to cause cardiac effects, including increased heart rate and decreased blood pressure. This compound is hydrophobic and has a high affinity for fatty acids. It also contains a hydroxyl group, which may cause metabolism by aminotransferase activity. The phase transition temperature of Delta8-Tetrahydrocannabinol is between 15°C and 16°C. The drug interactions of Delta8-Tetrahydrocannabinol are complex, as it is metabolized by cytochrome P450 enzymes, which can affect its pharmacological activity.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 314.46 g/mol
• Fórmula: C₂₁H₃₀O₂
• Pureza: Min. 95%
• Color/Forma: Clear Liquid